News
18h
Pharmaceutical Technology on MSNNewBiologix licenses cell line technology to Recipharm Advanced BioThe controlled cell line combined with Recipharm’s AAV manufacturing platform is said to allow for consistent and scalable ...
In this webinar, Nathan Sepulveda will share how to specifically and reproducibly measure residual HEK293 DNA during ...
Researchers just discovered super stem cells capable of resetting themselves back to a stronger, younger version.
A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...
5h
The Punch on MSNSickle cell and risk of blood clotsSickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for causing anaemia, pain episodes, and organ complications, but a lesser-known ...
ProBioGen inks agreement with Polpharma Biologics to provide high-performance cell line development services: Gdansk, Poland Friday, May 9, 2025, 17:00 Hrs [IST] ProBioGen, a Berl ...
University of Pennsylvania researchers have developed a powerful new investigative tool to reveal how proteins work inside ...
A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...
Medulloblastoma is one of the most common malignant tumors of the central nervous system (CNS) in children and adolescents.
Medulloblastomas, brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers have now analyzed the genetic changes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results